The first systematic review of 40 Hz light and sound in older adults: eight studies, and no consistent cognitive benefit

Every “a sound could reverse Alzheimer’s” headline traces back to the same small family of studies: gamma entrainment using sensory stimulation, or GENUS, in which people sit in front of a light flickering at 40 Hz with a 40 Hz tone playing. Until now nobody had put that family in one place and counted. Hyun and colleagues did, with a PROSPERO-registered protocol, PRISMA 2020 reporting, and searches of PubMed, Embase, Scopus and Web of Science covering January 2016 to December 2025. Eight studies in adults aged 60 and over qualified, running from a single session to six months.

They report domain by domain, and the domains do not agree with each other.

Where the news is best is brain structure. The controlled studies suggest 40 Hz stimulation may slow hippocampal atrophy, ventricular enlargement and white-matter decline. The authors pooled hippocampal and ventricular volume change in an exploratory random-effects meta-analysis, got favourable estimates, and then found those estimates did not hold up under conservative sensitivity analysis, which they say plainly.

Functional connectivity pointed the same hopeful way, suggesting possible preservation of networks that Alzheimer’s disease degrades. EEG confirmed that the stimulation does what it claims mechanically: the brain’s gamma rhythm follows the stimulus, with entrainment strength and spread varying by stimulation settings and by the individual. That is target engagement, and it is the least contested thing in the field.

The fluid biomarker evidence comes down to exploratory immune-related findings from one uncontrolled study. And on the outcome that matters to a person deciding whether to buy a device, the review’s verdict is flat: cognitive findings from the small exploratory studies did not establish a consistent benefit.

The authors’ conclusion is that human evidence for GENUS is “promising but preliminary and hypothesis-generating”, and that adequately powered standardised trials are needed before anyone draws efficacy conclusions. We grade it mixed, by the partial-findings override: favourable structural and mechanistic signals, no reliable cognitive effect, and a pooled result the authors themselves could not make robust.

This is the most useful paper we hold on 40 Hz, because it is independent, it is recent, and its framing matches what the evidence can carry. The kind of study it is summarising is visible in our entry on two years of daily 40 Hz light and sound in five people. It is also the record of what was known before the HOPE trial reports: that trial randomised 673 people against a sham and completed in August 2026, and whenever its results appear they will land on top of these eight small studies.

Limitations. Eight studies is a thin base, and their outcomes barely overlap, which is why the synthesis is narrative and the meta-analysis is labelled exploratory. The review’s own structural result failed its sensitivity check. The protocol was registered retrospectively rather than before the search. We could not read the full text: Springer refused the automated request, so risk-of-bias method, blinding across included studies and the funding statement are scored as unknown rather than guessed, and the request is logged in docs/reports/fulltext-requests.md. Reading it could raise this grade’s confidence and would settle three rubric criteria.